scholarly journals The effect of surgical site infection on the length of stay and health care costs

2011 ◽  
Vol 21 (1) ◽  
pp. 44-60 ◽  
Author(s):  
Jin-Hee Chang ◽  
Kyoung-Hoon Kim ◽  
Soon-Man Kwon ◽  
Seon-A Yeom ◽  
Choon-Seon Park
2019 ◽  
Vol 24 (3) ◽  
pp. 219-226 ◽  
Author(s):  
Keith B. Allen ◽  
Ethan Y. Brovman ◽  
Adnan K. Chhatriwalla ◽  
Katherine J. Greco ◽  
Nikhilesh Rao ◽  
...  

Purpose. Opioid-related adverse drug events (ORADEs) increase patient length of stay (LOS) and health care costs. However, ORADE rates may be underreported. This study attempts to understand the degree to which ORADEs are underreported in Medicare patients undergoing cardiac surgery. Materials and Methods. The Center for Medicare and Medicaid Services administrative claims database was used to identify ORADEs in 110 158 Medicare beneficiaries who underwent cardiac valve (n = 50 525) or coronary bypass (n = 59 633) surgery between April 2016 and March 2017. The International Classification of Disease (ICD)-10 codes specifically linked to ORADEs were used to identify an actual ORADE rate, while additional ICD codes, clinically associated with butas not specific to adverse drug events were analyzed as potential ORADEs. Length of stay (LOS) and hospital daily revenue were analyzed among patients with or without a potential ORADE. Results. Among patients undergoing valve or bypass surgery, the documented ORADE rate was 0.7% (743/110 158). However, potential ORADEs may have occurred in up to 32.4% (35 658/110 158) of patients. In patients with a potential ORADE, mean LOS was longer (11.4 vs 8.2 days; P < .0001) and mean Medicare revenue/day was lower ($4016 vs $4412; P < .0001). The mean net difference in revenue/day between patients with and without an ORADE varied between $231 and $1145, depending on the Diagnosis-Related Group analyzed. Conclusions. ORADEs are likely underreported following cardiac surgery. ORADEs can be associated with increased LOS and decreased hospital revenue. Understanding the incidence and economic impact of ORADEs may expedite changes to postoperative pain management. Adopting multimodal pain management strategies that reduce exposure to opioids may improve outcomes by reducing complications, side effects, and health care costs.


2014 ◽  
Vol 33 ◽  
pp. S73
Author(s):  
S. Klek ◽  
A. Hermanowicz ◽  
G. Dziwiszek ◽  
K. Matysiak ◽  
K. Szczepanek ◽  
...  

2012 ◽  
Vol 16 (4) ◽  
pp. 323-328 ◽  
Author(s):  
Scott L. Parker ◽  
David N. Shau ◽  
Stephen K. Mendenhall ◽  
Matthew J. McGirt

Object Revision lumbar fusion procedures are technically challenging and can be associated with tremendous health care resource utilization and cost. There is a paucity of data regarding specific factors that significantly contribute to increased cost of care. In light of this, the authors set out to identify independent risk factors predictive of increasing 2-year direct health care costs after revision lumbar fusion. Methods One hundred fifty patients undergoing revision instrument-assisted fusion for adjacent-segment disease (50 cases), pseudarthrosis (47 cases), or same-level stenosis (53 cases) were included in this study. Patient demographics, comorbidities, preoperative health states as assessed by patient-reported outcome questionnaires and perioperative complications were collected and analyzed. Two-year back-related medical resource utilization and direct health care costs were assessed. The independent association of all variables to increasing cost was assessed using multivariate linear regression analysis. Results There was a wide range ($24,935–$63,769) in overall 2-year direct costs for patients undergoing revision lumbar fusion (mean $32,915 ± $8344 [± SD]). Preoperative variables independently associated with 2-year direct health care costs included diagnosis of congestive heart failure, more severe leg pain (visual analog scale), greater back-related disability (Oswestry Disability Index), and worse mental health (12-Item Short Form Health Survey Mental Component Summary score). There was a 1.1- to 1.2-fold increase in cost for patients in the greatest quartiles compared with those in the lowest quartiles for these variables. Surgical site infection, return to the operating room, and spine-related hospital readmission during the 90-day global health period were postoperative variables independently associated with 2-year cost. Patients in the greatest versus lowest quartiles had a 1.7- to 1.9-fold increase in cost for these variables. Conclusions Revision lumbar fusion can be associated with considerable 2-year health care costs. These costs can also vary widely among patients, as evidenced by the 2.6-fold overall cost range in this series. Although comorbidities and preoperative severity of disease states contribute to cost of care, the primary drivers of increased cost include perioperative complications such as surgical site infection, return to the operating room, and readmission during the global health period. Measures focused on health service improvement will be most successful in reducing the cost of care for patients undergoing revision lumbar fusion.


2014 ◽  
Vol 33 ◽  
pp. S70
Author(s):  
S. Klek ◽  
A. Hermanowicz ◽  
G. Dziwiszek ◽  
K. Szczepanek ◽  
P. Szybinski ◽  
...  

2014 ◽  
Vol 186 (2) ◽  
pp. 608-609
Author(s):  
P.R. Fillmore ◽  
B. Armstrong ◽  
M. Johnson ◽  
S. Tsuda ◽  
T. Browder ◽  
...  

2015 ◽  
Vol 23 (3) ◽  
pp. 615-617 ◽  
Author(s):  
Ranjan Pathak ◽  
Smith Giri ◽  
Madan Raj Aryal ◽  
Paras Karmacharya ◽  
Vijaya Raj Bhatt ◽  
...  

2015 ◽  
Vol 13 (11) ◽  
pp. 399-404 ◽  
Author(s):  
Sofya Pintova ◽  
Randall Holcombe ◽  
Seth Blacksburg ◽  
Philip Friedlander

2014 ◽  
Vol 100 (2) ◽  
pp. 609-615 ◽  
Author(s):  
Stanislaw Klek ◽  
Adam Hermanowicz ◽  
Grzegorz Dziwiszek ◽  
Konrad Matysiak ◽  
Kinga Szczepanek ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document